MassBio® Is Pleased to Announce a New Partnership with Morgan Stanley, Providing Even More Services and Value to Its Members

May 04, 2022

The international firm will offer MassBio member companies competitive retirement programs through the EdgeBenefits program

May 4, 2022 (CAMBRIDGE, MA) – The Massachusetts Biotechnology Council (MassBio®) today announced that Morgan Stanley, the global financial services company, has joined its EdgeBenefits program as a Preferred Partner. By aggregating the purchasing power of the 1,500+ member companies within MassBio, MassBioEdge allows members to have a strong presence in the marketplace and benefit from competitive discounts and premier customer service, which saves members more than $200 million each year. The EdgeBenefits program offers best in class plans for MassBio members including a comprehensive array of medical, dental, life and disability, vision, and wealth management plans.

The Morgan Stanley at Work program is a comprehensive suite of workplace financial solutions built around the belief that when employees thrive, companies benefit. They seek to build employee financial confidence and help companies attract and retain top talent. Their end-to-end offering spans equity compensation, financial wellness, and retirement solutions, and they provide all employees with financial empowerment, so they have the knowledge, tools, and support needed to make the most of their workplace financial benefits. 

Morgan Stanley At Work EdgeBenefits group retirement program will provide MassBio members with two turnkey 401(k) retirement solutions based on their company size. Morgan Stanley will provide MassBio members with pre-negotiated pricing to reduce administrative and investment expenses; a dedicated relationship manager and specialists; payroll integration with the top payroll providers; access to a dedicated financial advisor team for assistance with plan design, vendor oversight, among other consulting services; and access to Morgan Stanley’s employee education resources.

“The Massachusetts life sciences cluster is largely comprised of small and emerging biotechs which are often pre-clinical and pre-revenue and working to address some of the world’s greatest unmet medical needs,” said Jason Cordeiro, Chief Business Officer, MassBio. “We are proud to welcome Morgan Stanley to our leading MassBio EdgeBenefitsprogram to support the growth of this cohort and ensure the entire ecosystem of companies that make up our cluster have all the resources and savings possible to invest in research and development.”

“Morgan Stanley is excited to partner with MassBio and offer its member companies innovative and affordable retirement programs that meets the needs of their employees,” said Joseph Malarney, Managing Director and Complex Manager at Morgan Stanley.

For more information about Morgan Stanley and to view benefit highlights, please visit the MassBioEdge website.

See all MassBio News